205 related articles for article (PubMed ID: 38040838)
1. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models.
Cho E; Mun SJ; Kim HK; Ham YS; Gil WJ; Yang CS
Acta Pharmacol Sin; 2024 Mar; 45(3):581-593. PubMed ID: 38040838
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
[TBL] [Abstract][Full Text] [Related]
3. Computational Deciphering of the Role of S100A8 and S100A9 Proteins and Their Changes in the Structure Assembly Influences Their Interaction with TLR4, RAGE, and CD36.
Paramasivam S; Perumal SS; Ekambaram SP
Protein J; 2024 Apr; 43(2):243-258. PubMed ID: 38431537
[TBL] [Abstract][Full Text] [Related]
4. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis.
Turovskaya O; Foell D; Sinha P; Vogl T; Newlin R; Nayak J; Nguyen M; Olsson A; Nawroth PP; Bierhaus A; Varki N; Kronenberg M; Freeze HH; Srikrishna G
Carcinogenesis; 2008 Oct; 29(10):2035-43. PubMed ID: 18689872
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells.
Wang L; Luo H; Chen X; Jiang Y; Huang Q
PLoS One; 2014; 9(3):e90472. PubMed ID: 24595267
[TBL] [Abstract][Full Text] [Related]
6. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
7. S100A8/A9: From basic science to clinical application.
Pruenster M; Vogl T; Roth J; Sperandio M
Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899
[TBL] [Abstract][Full Text] [Related]
8. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
[TBL] [Abstract][Full Text] [Related]
9. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
10. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo.
Chen B; Miller AL; Rebelatto M; Brewah Y; Rowe DC; Clarke L; Czapiga M; Rosenthal K; Imamichi T; Chen Y; Chang CS; Chowdhury PS; Naiman B; Wang Y; Yang D; Humbles AA; Herbst R; Sims GP
PLoS One; 2015; 10(2):e0115828. PubMed ID: 25706559
[TBL] [Abstract][Full Text] [Related]
11. Involvement of S100A8/A9-TLR4-NLRP3 Inflammasome Pathway in Contrast-Induced Acute Kidney Injury.
Tan X; Zheng X; Huang Z; Lin J; Xie C; Lin Y
Cell Physiol Biochem; 2017; 43(1):209-222. PubMed ID: 28854431
[TBL] [Abstract][Full Text] [Related]
12. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants.
Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D
Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
Nakajima Y; Inagaki Y; Kido J; Nagata T
Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
[TBL] [Abstract][Full Text] [Related]
14. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
[TBL] [Abstract][Full Text] [Related]
15. Angelica oil restores the intestinal barrier function by suppressing S100A8/A9 signalling in mice with ulcerative colitis.
Liu C; He YX; Zhang JN; Yang F; Wang SY; Hu JL; Yu Y
Phytomedicine; 2023 Jan; 108():154490. PubMed ID: 36332386
[TBL] [Abstract][Full Text] [Related]
16. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
17. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
[TBL] [Abstract][Full Text] [Related]
18. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
19. Differential release and deposition of S100A8/A9 proteins in inflamed upper airway tissue.
Van Crombruggen K; Vogl T; Pérez-Novo C; Holtappels G; Bachert C
Eur Respir J; 2016 Jan; 47(1):264-74. PubMed ID: 26493794
[TBL] [Abstract][Full Text] [Related]
20. The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9.
Möller A; Jauch-Speer SL; Gandhi S; Vogl T; Roth J; Fehler O
Front Immunol; 2023; 14():1110185. PubMed ID: 37056775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
